Median, minimum (min) and maximum (max) of the early and late evolution score are indicated per treatment: platelet-rich plasma (PRP), native mesenchymal stem cells (MSCs), combination (Comb) 1 (native MSCs and PRP) or Comb 2 (chondrogenic induced MSCs and PRP).
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://figshare.com/articles/dataset/_Median_minimum_min_and_maximum_max_of_the_early_and_late_evolution_score_are_indicated_per_treatment_platelet_rich_plasma_PRP_native_mesenchymal_stem_cells_MSCs_combination_Comb_1_native_MSCs_and_PRP_or_Comb_2_chondrogenic_induced_MSCs_and_PRP_/904625
下载链接
链接失效反馈官方服务：
资源简介：
The “early” score indicates the average of the clinical evolution scores at 6 weeks and 12 weeks, whereas “late” indicates the average of the clinical evolution scores at 6 months and 12 months after treatment.
创建时间：
2014-01-20
